ライフサイエンスコーパス: 5-HT

1 5-HT increased frequency of sIPSCs without affecting pos

2 5-HT increased vesicular GABA release in naive and depen

3 5-HT(2A) activation gave rise to stress fibers in these

4 5-HT(2A)R agonist-induced head-twitch behavior was also

5 5-HT(2A,) a G-protein coupled receptor, is widely expres

6 5-HT(3) receptors are pentameric ligand-gated ion channe

7 5-HT(7) drives the acquisition of profibrotic and anti-i

8 5-HT(7) receptors in their inactive state associate with

9 5-HT-ir neurons were also observed within the vocal moto

10 Serotonin 1A (5-HT(1A)) autoreceptors regulate brain-wide serotonin ne

11 r 1 (TAAR1) and 5-hydroxytryptamine type 1A (5-HT(1A)) receptors, may represent a new class of psycho

12 01854944) was to assess D(2)/D(3), 5-HT(1A), 5-HT(2A) and serotonin transporter (SERT) occupancies of

13 ctional evidence for the existence of MT(2) /5-HT(2C) heteromeric complexes in mouse brain.

14 ata and indicating the involvement of MT(2) /5-HT(2C) heteromers. The antidepressant agomelatine had

15 ties exhibited by the compounds in 5-HT(2A), 5-HT(2A)/mGlu(2), and 5-HT(2A)/mGlu(2)/Gqo5 cells.

16 ose dependent manner, while binding to D(3), 5-HT(1A) receptors and SERT was not detectable with the

17 study (NCT01854944) was to assess D(2)/D(3), 5-HT(1A), 5-HT(2A) and serotonin transporter (SERT) occu

18 ons of the homomeric 5-hydroxytryptamine 3A (5-HT(3A)) serotonin receptor for 15 to 20 mus to demonst

19 The serotonin type 3A (5-HT(3A)) receptor is a homopentameric cation-selective

20 that antagonizing serotonin (5-HT) type 3AB (5-HT(3AB)) receptors in brain areas involved in mood reg

21 Thus, 12 is reported as a 5-HT(2C)R PAM with characteristics suitable for in vivo

22 Compound 12 (CTW0415) was discovered as a 5-HT(2C)R PAM with improved pharmacokinetics and reduced

23 stimulation of beta-cells were blocked by a 5-HT(3)R antagonist and were enhanced by increasing sero

24 everted more rapidly to baseline following a 5-HT-challenge.

25 lthy volunteers were randomly allocated to a 5-HT depletion (N = 24), DA depletion (N = 24), or place

26 Accordingly, 5-HT abolished spontaneous neuronal firing in naive and

27 Our findings suggest that activating 5-HT(4)R acutely in the mPFC or targeting mPFC pyramidal

28 We evaluated whether acute 5-HT(4)R activation in glutamatergic axon terminals aris

29 havioral and neural responses observed after 5-HT depletion in the current study closely resemble our

30 lowing the formation of conventional agonist-5-HT(7)-G(s) ternary complexes and subsequent G(s) activ

31 In the absence of agonists, 5-HT(2A)R was primarily localized within intracellular c

32 en the two receptors in 5-HT(2A)/mGlu(2) and 5-HT(2A)/mGlu(2)/Gqo5 cells.

33 nist SB-243213, and were absent in MT(2) and 5-HT(2C) knockout mice, fully recapitulating previous in

34 compounds in 5-HT(2A), 5-HT(2A)/mGlu(2), and 5-HT(2A)/mGlu(2)/Gqo5 cells.

35 (2A)-, mGlu(2)/Gqo5-, 5-HT(2A)/mGlu(2)-, and 5-HT(2A)/mGlu(2)/Gqo5-expressing HEK293 cells using a Ca

36 of the 5-HT(2A) (5-hydroxytryptamine 2A) and 5-HT(1A) (5-hydroxytryptamine 1A) receptors.

37 on of serotonin receptors, with 5-HT(2B) and 5-HT(7) expression restricted to M-CSF-primed monocyte-d

38 hibits 5-HT-induced currents in 5-HT(3A) and 5-HT(3AB) receptors considerably.

39 top of contractions induced by KCl, ACh and 5-HT.

40 l-emotion processing and brain dynamics, and 5-HT abnormalities have been consistently implicated in

41 that mostly colocalized PDF, FMRFamide, and 5-HT immunoreactivities, and with terminals of ipsi- and

42 These results suggest that glutamate and 5-HT, released by NTS afferent terminals, trigger Ca(2+)

43 tor pathways regenerated into the graft, and 5-HT(+) neurons within graft and host brainstem neurons

44 Na(V)1.8(-/-) impaired histamine and 5-HT-induced scratching while Na(V)1.9 was involved in i

45 Concurrent 5-HT(2A) (Q pathway) and 5-HT(7) (S pathway) serotonin receptor activation cancel

46 to the selectivity of spiperone to D(2)R and 5-HT(2A)R.

47 ents, glutamate acting at AMPA receptors and 5-HT acting at 5-HT(2A) receptors.

48 trated in vivo binding to D(2) receptors and 5-HT(2A) receptors at steady state after 10 days of dail

49 The inhibition of 5-HT(3A)Rs and 5-HT(3AB)Rs was non-use dependent and voltage independen

50 gonism at trace amine receptor 1 (TAAR1) and 5-HT(1A) receptors but no appreciable action at dopamine

51 namic range of agonist-induced signaling, as 5-HT(7) receptors spontaneously activate G(s) variants t

52 ed 5-HT staining in SK-N-SH cells as well as 5-HT concentrations in the culture media and cell lysate

53 acting at AMPA receptors and 5-HT acting at 5-HT(2A) receptors.

54 Negligible occupancy (<5%) was observed at 5-HT(1A) and SERT at 4 mg/day.

55 dose-related occupancy was also observed at 5-HT(2A) receptors.

56 Because 5-HT(2B) mediates clinically relevant 5-HT-related patho

57 Behaviorally, 5-HT depleted subjects demonstrated impaired social rewa

58 A strong positive correlation between 5-HT(+) GCs and reductions in spongiotrophoblast to GC a

59 anism that involved heteromerization between 5-HT(2A)R and mGluR2.

60 -ICD is required for the interaction between 5-HT(3A) and the chaperone protein resistance to inhibit

61 responses in 5-HT(2A)/mGlu(2) cells and both 5-HT- and Glu-induced responses in 5-HT(2A)/mGlu(2)/Gqo5

62 mulation results of apo- and serotonin-bound 5-HT(3A)R, the study reveals a distinct interaction fing

63 tion regarding the orthosteric activation by 5-HT and by the partial agonist tryptamine, and the allo

64 diazepam (1.5 mug/side) were also blocked by 5-HT depletion.

65 osteric regulation of ion gating elements by 5-HT binding is indicative of a preactive state, which p

66 lease was attenuated, suggesting blunted CeA 5-HT sensitivity, which partially recovered in protracte

67 Here, we examined neuroadaptations of CeA 5-HT signaling in adult, male Sprague Dawley rats using

68 em and unravels the vulnerability of the CeA 5-HT system to chronic alcohol and protracted withdrawal

69 of firing rate of DRN 5-HT neurons, cerebral 5-HT depletion, and optogenetic activation and silencing

70 n addition, we comprehensively characterized 5-HT-immunoreactive (-ir) innervation throughout the bra

71 Concurrent 5-HT(2A) (Q pathway) and 5-HT(7) (S pathway) serotonin r

72 ll vocal midbrain nuclei showed considerable 5-HT-ir innervation, as did thalamic and hindbrain audit

73 By contrast, 5-HT signaling (via the RNi-related pathways) is associa

74 impairment, but not increased frontal cortex 5-HT(2A)R density or psychedelic-induced head-twitch beh

75 inococcaceae, correlated with frontal cortex 5-HT(2A)R density.

76 i.e., 32 pM, 31 pM, 64 pM, and 9 pM for DA, 5-HT, Epn, and Norepn, respectively.

77 and ERICH3 knock-out dramatically decreased 5-HT staining in SK-N-SH cells as well as 5-HT concentra

78 Ethanol treatment resulted in decreased 5-HT concentrations in human induced pluripotent stem ce

79 It may thus be the case that decreased 5-HT levels contribute to social learning deficits in de

80 These changes presumably lead to decreased 5-HT synthesis and/or increased 5-HT reuptake, thereby r

81 tional knockout male mice supports deficient 5-HT transmission underlying depression-related phenotyp

82 While previous studies have described 5-HT distribution in various teleosts, serotonergic raph

83 Expanding upon our recently described 5-HT(2C)R-positive allosteric modulators (PAMs) based on

84 ed fast anxiolytic effects and increased DRN 5-HT cell firing.

85 it, in vivo recordings of firing rate of DRN 5-HT neurons, cerebral 5-HT depletion, and optogenetic a

86 posure and protracted withdrawal dysregulate 5-HT signaling in the CeA.

87 Agonists for either 5-HT(2A)R or mGluR2 differentially affected trafficking

88 )R) allosteric site to potentiate endogenous 5-HT tone may provide novel therapeutics to alleviate th

89 ve panel of pruritogens (C48/80, endothelin, 5-HT, chloroquine, histamine, lysophosphatidic acid, try

90 (5-HT) in the mammalian brain, and excessive 5-HT signaling is critically implicated in the etiology

91 eus, the major source of 5-HT, and expresses 5-HT receptor subtypes (e.g., 5-HT2C and 5-HT1A) critica

92 CE) using chitosan as cross-linked agent for 5-HT sensing studies; conducted through cyclic voltammet

93 that terpenoids are efficacious agonists for 5-HT(3)A receptors.

94 ancy; Cohort 2 received [(11)C]MDL100907 for 5-HT(2A) occupancy and [(11)C]DASB for SERT occupancy; C

95 of 63 +/- 11 nM for DA and 40 +/- 17 nM for 5-HT through a wide concentration range (40 nM-200 muM).

96 anomolar detection limit of 63 +/- 11 nM for 5-HT through a wide concentration range (63 nM-200 muM)

97 ty to ZCNT 0.1 NCs as compared to others for 5-HT sensing studies.

98 Here we report a novel role for 5-HT(2A) in cell-matrix adhesion.In HEK293 cells, which

99 ants for gating and priming were similar for 5-HT and terpenoid activation.

100 ts demonstrate the existence of a functional 5-HT/5-HT(2B)/AhR axis in human macrophages and indicate

101 nteraction, we developed different MBP-fused 5-HT(3A)-ICD constructs by deleting large segments of it

102 e characterized in 5-HT(2A)-, mGlu(2)/Gqo5-, 5-HT(2A)/mGlu(2)-, and 5-HT(2A)/mGlu(2)/Gqo5-expressing

103 on mouse homomeric 5-HT(3A) and heteromeric 5-HT(3AB) receptors expressed in Xenopus laevis oocytes

104 hibited 5-HT-induced currents in heteromeric 5-HT type 3AB receptors (5-HT(3AB)Rs) (IC(50) = 840 and

105 onstrate that bupropion inhibits heteromeric 5-HT(3AB)Rs as well as homomeric 5-HT(3A)Rs.

106 effects that bupropion exerts on heteromeric 5-HT(3AB) receptors, in particular when constantly prese

107 t ligands targeting the putative heteromeric 5-HT(2A)/mGlu(2) receptor complex, based on the 5-HT(2A)

108 Serotonin turnover (ratio 5-HIAA/5-HT) was reduced in exposed females and males after 28

109 he correlation between raphe and hippocampal 5-HT(1A) binding which was more pronounced in HV.

110 Correlation between hippocampal 5-HT(1A) binding and the hippocampal inhibition network

111 s, IFG and dmPFC correlated with hippocampal 5-HT(1A) binding.

112 heteromeric 5-HT(3AB)Rs as well as homomeric 5-HT(3A)Rs.

113 bupropion and hydroxybupropion for homomeric 5-HT(3A)Rs were 10- and 5-fold lower, respectively (87 a

114 tabolite hydroxybupropion on mouse homomeric 5-HT(3A) and heteromeric 5-HT(3AB) receptors expressed i

115 shown to be an antagonist at homopentameric 5-HT type 3A receptors.

116 To date, however, no one has examined how 5-HT influences the dynamics of facial-emotion processin

117 Targeting the serotonin (5-HT) 5-HT(2C) receptor (5-HT(2C)R) allosteric site to potenti

118 By constructing a high-conductance human 5-HT(3)A receptor, we here revealed mechanistic informat

119 e of the vestibule binding site to the human 5-HT(3) receptor, suggesting a common mechanism of modul

120 g the activation and modulation of the human 5-HT(3) type A receptor has been based only on macroscop

121 ot only extend our knowledge about the human 5-HT(3)A molecular function but also provide novel insig

122 inding and unbinding of 5-hydroxytryptamine (5-HT) (i.e., serotonin) to the binding pocket located on

123 hown that the selective 5-hydroxytryptamine (5-HT) (serotonin) reuptake inhibitor (SSRI) fluoxetine (

124 5-hydroxytryptamine (5-HT) is equipped onto nanoparticles (NPs) loaded with p

125 ng the neurotransmitter 5-hydroxytryptamine (5-HT).

126 smitters, estimation of 5-hydroxytryptamine (5-HT; Serotonin) release has proved to be challenging.

127 y peripheral serotonin (5-hydroxytryptamine [5-HT]).

128 Selective deletion of AdipoR1 in 5-HT neurons induced anhedonia in male mice, as indicate

129 male but not female mice lacking AdipoR1 in 5-HT neurons.

130 heterobivalent ligands were characterized in 5-HT(2A)-, mGlu(2)/Gqo5-, 5-HT(2A)/mGlu(2)-, and 5-HT(2A

131 ing affinities exhibited by the compounds in 5-HT(2A), 5-HT(2A)/mGlu(2), and 5-HT(2A)/mGlu(2)/Gqo5 ce

132 conditions inhibits 5-HT-induced currents in 5-HT(3A) and 5-HT(3AB) receptors considerably.

133 lk was observed between the two receptors in 5-HT(2A)/mGlu(2) and 5-HT(2A)/mGlu(2)/Gqo5 cells.

134 ligands inhibited 5-HT-induced responses in 5-HT(2A)/mGlu(2) cells and both 5-HT- and Glu-induced re

135 and both 5-HT- and Glu-induced responses in 5-HT(2A)/mGlu(2)/Gqo5 cells.

136 to decreased 5-HT synthesis and/or increased 5-HT reuptake, thereby reducing 5-HT transmission.

137 g pathway specifically in EC cells to induce 5-HT secretion.

138 propion with 5-HT dose dependently inhibited 5-HT-induced currents in heteromeric 5-HT type 3AB recep

139 lities, the seven bivalent ligands inhibited 5-HT-induced responses in 5-HT(2A)/mGlu(2) cells and bot

140 mimics therapeutic drug conditions inhibits 5-HT-induced currents in 5-HT(3A) and 5-HT(3AB) receptor

141 ructs that are unable to form the interclass 5-HT(2A)R-mGluR2 complex, we demonstrated that heteromer

142 gions in the superior raphe, an intermediate 5-HT-ir cell cluster, and an extensive inferior raphe po

143 imulate human and mouse Trpa1 and intestinal 5-HT secretion.

144 ug intake, genetically predisposed irregular 5-HT receptor density, or change in sensory bombardment

145 that the 5-HT-mediated activation of AhR is 5-HT(2B) dependent because it is abrogated by the 5-HT(2

146 elatonin-promoted G(q) activation due to its 5-HT(2C) antagonistic component.

147 ata show that in addition to (R,S)-ketamine, 5-HT(4)R agonists are also effective prophylactics again

148 resolution cryo-EM structures of full-length 5-HT(3A)R in complex with palonosetron, ondansetron, and

149 serotonin (5-HT) concentrations, and lowered 5-HT GC immunoreactivity.

150 In addition, three major 5-HT-ir cell groups were identified in the hypothalamus

151 ptor occupancy and [(11)C]CUMI101 to measure 5-HT(1A) occupancy; Cohort 2 received [(11)C]MDL100907 f

152 IL-33-mediated 5-HT release activated enteric neurons, subsequently pro

153 ver, the detailed mechanisms underlying mPFC 5-HT(1A) receptor-mediated antidepressant-like effects a

154 d arise by either the expression of multiple 5-HT receptors (5-HTRs) on the same cells or by populati

155 ong enough to observe complete activation of 5-HT(3A), the allosteric regulation of ion gating elemen

156 Our findings reveal that the activity of 5-HT(DR->VTA) neurons may be an essential factor in dete

157 cial stress decreased the firing activity of 5-HT(DR->VTA) neurons.

158 Subsequent pharmacological blockade of 5-HT(2A) receptors with ketanserin in RN-NSC-grafted rat

159 racellular compartments, and coexpression of 5-HT(2A)R with mGluR2 increased the intracellular distri

160 n, TSPAN5 can modulate the concentrations of 5-HT and kynurenine.

161 xclusively to detect basal concentrations of 5-HT.

162 etermine the transcriptional consequences of 5-HT(2B) engagement in human macrophages, for which 5-HT

163 using Ni(3)HHTP(2) MOFs for the detection of 5-HT with a nanomolar detection limit of 63 +/- 11 nM fo

164 However, the effects of 5-HT in olfaction are likely complicated, because multip

165 (BDNF) in the antidepressant-like effects of 5-HT(1A) receptor activation in the mPFC.

166 l lysates without changing the expression of 5-HT synthesizing or metabolizing enzymes.

167 The expression of 5-HT(2A)R also augmented intracellular localization of m

168 )(frontal) baseline) was used as an index of 5-HT release.

169 Therefore, we compared the influence of 5-HT on the responsivity of brain dynamics during facial

170 nt increase in adhesion, while inhibition of 5-HT(2A) by antipsychotics, such as risperidone, olanzap

171 The inhibition of 5-HT(3A)Rs and 5-HT(3AB)Rs was non-use dependent and vol

172 d that citalopram (which increases levels of 5-HT) caused sustained activation in key limbic regions

173 portantly, the bidirectional manipulation of 5-HT(DR->VTA) neurons could modulate susceptibility to s

174 offers new insights into the organization of 5-HT nuclei in teleosts and provides neuroanatomical evi

175 Here we show that preassociation of 5-HT(7) serotonin receptors with G(s) heterotrimers is n

176 to long-duration clusters in the presence of 5-HT and even longer in the presence of terpenoids, wher

177 The MPO targeting property of 5-HT modified NPs is confirmed by noninvasive positron e

178 downregulated with a concurrent reduction of 5-HT-immunoreactivity in the DRN and its two major proje

179 d be sensed by EC cells, inducing release of 5-HT.

180 Notably, the role of 5-HT regulating rat CeA activity in alcohol dependence i

181 itude longer than any previous simulation of 5-HT(3A), allow us to observe the dynamic binding and un

182 he dorsal raphe nucleus, the major source of 5-HT, and expresses 5-HT receptor subtypes (e.g., 5-HT2C

183 sults indicate that selective stimulation of 5-HT(1A) receptor in the mPFC exerts rapid and sustained

184 udies, we present an argument for the use of 5-HT(1A) agonists in the treatment of Dup15q epilepsy.

185 ur results indicate that adiponectin acts on 5-HT neurons through AdipoR1 receptors to regulate depre

186 iological function of TSPAN5 with a focus on 5-HT and kynurenine concentrations in the tryptophan pat

187 r, they add to an emerging view that NAC, or 5-HT(1B/1D/1F) receptor agonist treatment, may be a prom

188 nal secretagogues, drugs acting on opioid or 5-HT receptors, or minimally absorbed antibiotics (all o

189 eaches the AL via the diffusion of paracrine 5-HT through the fly hemolymph [8] and by activation of

190 In addition, overnight pharmacological 5-HT(2A)R blockade with clozapine, but not with M100907,

191 by which it might be associated with plasma 5-HT concentrations and SSRI clinical response remained

192 The presented 5-HT(1A) receptor-biased agonists, preferentially target

193 ndicative of neuroadaptations of presynaptic 5-HT receptors.

194 ET) using [(11)C]CUMI-101 (CUMI) to quantify 5-HT(1A) binding in midbrain raphe nuclei and functional

195 investigated the relationship between raphe 5-HT(1A) binding and brain-wide network dynamics of nega

196 d connectivity was not associated with raphe 5-HT(1A) binding.

197 une-neuroendocrine axis in calibrating rapid 5-HT release for intestinal homeostasis.

198 , expression and stimulation of human or rat 5-HT(2A) receptor by agonists such as serotonin or 2,5-d

199 ly through stimulation of serotonin receptor 5-HT(1A).

200 related peptide, and the serotonin receptor 5-HT(3)R.

201 frontal cortex serotonin 5-HT(2A) receptor (5-HT(2A)R) density in the adult offspring, a phenotype p

202 addition to the serotonin 5-HT(2A) receptor (5-HT(2A)R), the dopamine D(2) receptor (D(2)R) is a key

203 ting the serotonin (5-HT) 5-HT(2C) receptor (5-HT(2C)R) allosteric site to potentiate endogenous 5-HT

204 The serotonin type 3 receptor (5-HT(3)) is a ligand-gated ion channel that converts the

205 rgic compounds such as serotonin 4 receptor (5-HT(4)R) agonists could act as prophylactics.

206 effects of specific serotoninergic receptor (5-HT(2A)R) stimulation with psilocybin in healthy humans

207 at the class A serotonin 5-HT(2A) receptors (5-HT(2A)Rs) affected the localization and trafficking of

208 line and serotonin (5-HT) type 3A receptors (5-HT(3A)Rs).

209 ents in heteromeric 5-HT type 3AB receptors (5-HT(3AB)Rs) (IC(50) = 840 and 526 muM, respectively).

210 vation of serotonin (5-HT) type 4 receptors (5-HT(4)Rs) has been shown to have anxiolytic effects in

211 Serotonin receptors (5-HT(3A)R) play a crucial role in regulating gut movemen

212 or increased 5-HT reuptake, thereby reducing 5-HT transmission.

213 ecause 5-HT(2B) mediates clinically relevant 5-HT-related pathologies (valvular heart disease, pulmon

214 12 to potentiate the effects of a selective 5-HT(2C)R agonist was established in a drug discriminati

215 ed to obtain PZ-1361, a potent and selective 5-HT(7) receptor antagonist, with antidepressant propert

216 of hemodynamics, we implanted serotonergic (5-HT(+)) neuron-enriched embryonic raphe nucleus-derived

217 Here, we showed that the class A serotonin 5-HT(2A) receptors (5-HT(2A)Rs) affected the localizatio

218 ed up-regulation of frontal cortex serotonin 5-HT(2A) receptor (5-HT(2A)R) density in the adult offsp

219 MT(2) receptors and G(q) -coupled serotonin 5-HT(2C) receptors, in which melatonin transactivates ph

220 high affinity and selectivity for serotonin 5-HT(1A) receptors were obtained and tested in four func

221 In addition to the serotonin 5-HT(2A) receptor (5-HT(2A)R), the dopamine D(2) recepto

222 Serotonin (5-HT) and dopamine are critical neuromodulators known to

223 Serotonin (5-HT) is a modulator of neural circuitry underlying moto

224 Serotonin (5-HT) represents a quintessential neuromodulator, having

225 Serotonin (5-HT) selective reuptake inhibitors (SSRIs) are widely u

226 ed with altered dopamine (DA) and serotonin (5-HT) functioning, the current study aimed to elucidate

227 opamine (DA), uric acid (UA), and serotonin (5-HT) in 0.1 M PBS (pH = 7.4).

228 ibits nicotinic acetylcholine and serotonin (5-HT) type 3A receptors (5-HT(3A)Rs).

229 gnaling-such as dopamine (DA) and serotonin (5-HT)-have been independently detected in psychiatric di

230 tudies indicate that antagonizing serotonin (5-HT) type 3AB (5-HT(3AB)) receptors in brain areas invo

231 eroendocrine signalling compound, serotonin (5-HT), is important for regulating peristaltic motion, f

232 ransmitters, i.e., dopamine (DA), serotonin (5-HT), epinephrine (Epn), and norepinephrine (Norepn), u

233 Herein, the efficient serotonin (5-HT) sensing studies have been conducted using the (ZnO

234 Excessive serotonin (5-HT) signaling plays a critical role in the etiology of

235 translate environmental cues into serotonin (5-HT) production, contributing to intestinal physiology.

236 Moreover, serotonin (5-HT) has been shown to be a key regulator of both facia

237 e binding of the neurotransmitter serotonin (5-HT) into a transient cation current that mediates fast

238 raphe nucleus, the main source of serotonin (5-HT) in the mammalian brain, and excessive 5-HT signali

239 hydroxylase 2 (TPH2), a marker of serotonin (5-HT) neurons.

240 recordings, and iontophoresis of serotonin (5-HT) receptor antagonists in the mouse visual cortex.

241 Activation of serotonin (5-HT) type 4 receptors (5-HT(4)Rs) has been shown to hav

242 cantly increased plasma levels of serotonin (5-HT), and serotonin molecule and SCA plasma induced neu

243 M), acetylcholine (ACh 10 muM) or serotonin (5-HT 10 muM).

244 zone, markedly reduced placental serotonin (5-HT) concentrations, and lowered 5-HT GC immunoreactivi

245 SPAN5 were associated with plasma serotonin (5-HT) concentrations which were themselves associated wi

246 nificantly associated with plasma serotonin (5-HT) concentrations, which were themselves associated w

247 Targeting the serotonin (5-HT) 5-HT(2C) receptor (5-HT(2C)R) allosteric site to p

248 grees of conformational change in the setron-5-HT(3A)R structures, throughout the channel and particu

249 Significant 5-HT-ir innervation was found in components of the vocal

250 Since 5-HT(2A) is associated with many disorders such as demen

251 tal cortex (mPFC), as opposed to the somatic 5-HT(1A) autoreceptor, has been shown to play a critical

252 Inactive-state 5-HT(7)-G(s) complexes are required for the full dynamic

253 Inactive-state 5-HT(7)-G(s) complexes dissociate in response to agonist

254 d-amphetamine challenge to evaluate synaptic 5-HT changes in the living human brain.

255 transmembrane domain (TMD) from synergistic 5-HT binding.

256 by activating PV interneurons and by a TAAR1/5-HT(1A) agonist.

257 Moreover, we found that 5-HT dose dependently upregulates the expression of AhR

258 These results indicate that 5-HT depletion impairs learning from social rewards, on

259 axis in human macrophages and indicate that 5-HT potentiates the activity of a transcription factor

260 l modeling-based fMRI analyses revealed that 5-HT depletion altered social reward prediction signals

261 ecific agonists and antagonist revealed that 5-HT(2B) engagement modifies the cytokine and gene signa

262 Additionally, we have shown that 5-HT(3A)-ICD fused to maltose-binding protein (MBP) dire

263 on modulator N-acetyl cysteine (NAC) and the 5-HT(1B/1D/1F) receptor agonist eletriptan to normalise

264 determinant for the interaction between the 5-HT(3A)-ICD and RIC-3.

265 ights into modulation of CeA activity by the 5-HT system and unravels the vulnerability of the CeA 5-

266 2B) dependent because it is abrogated by the 5-HT(2B)-specific antagonist SB204741.

267 These effects were inhibited by the 5-HT(2C) receptor-specific inverse agonist SB-243213, an

268 on in the mPFC, and provide evidence for the 5-HT(1A) receptor as a target for the treatment of MDD.

269 that heteromerization was necessary for the 5-HT(2A)R-dependent effects on mGluR2 subcellular distri

270 Furthermore, the 5-HT(4) receptor agonist prucalopride increases enteric

271 Mechanistically, the 5-HT(2A)-mediated adhesion was mediated by downstream PK

272 results show that intra-mPFC infusion of the 5-HT(1A) receptor agonist 8-OH-DPAT induces rapid and lo

273 In particular, selective stimulation of the 5-HT(1A) receptor in the medial prefrontal cortex (mPFC)

274 Finally, selective stimulation of the 5-HT(1A) receptor increased levels of synaptic proteins

275 with spatial gene expression patterns of the 5-HT(2A) (5-hydroxytryptamine 2A) and 5-HT(1A) (5-hydrox

276 e not understood, although activation of the 5-HT(2A) serotonin receptor (HTR2A) is key.

277 es in cells expressing each component of the 5-HT(2A)R-mGluR2 heterocomplex alone, or together.

278 Using a simplified model of the pore of the 5-HT(3) receptor (5HT3R) which restrains the backbone st

279 identify a 24-amino-acid-long segment of the 5-HT(3A)-ICD as a molecular determinant for the interact

280 T(2A)/mGlu(2) receptor complex, based on the 5-HT(2A) antagonist MDL-100,907 and the mGlu(2) ago-PAM

281 synthesized monovalent ligands retained the 5-HT(2A) antagonist and mGlu(2) ago-PAM functionalities,

282 Previously, we have demonstrated that the 5-HT(3A)-ICD is required for the interaction between 5-H

283 ylactics against stress, suggesting that the 5-HT(4)R may be a novel target for prophylactic drug dev

284 ion of AhR target genes in M-MO and that the 5-HT-mediated activation of AhR is 5-HT(2B) dependent be

285 co-chemical properties in correlation to the 5-HT sensing activity.

286 eritoneally) or intra-mPFC infusion with the 5-HT(4)R agonist, RS67333 (0.5 mug/side), were examined

287 In dependent rats, this 5-HT-induced increase of GABA release was attenuated, su

288 We tested if three 5-HT(4)R agonists with varying affinity could protect ag

289 transactivates phospholipase C (PLC) through 5-HT(2C) .

290 Thus, 5-HT input provides balanced but distinct suppressive ef

291 odes exhibit higher sensing activity towards 5-HT in accordance to its higher surface area, lower par

292 )1.9 was involved in itch signalling towards 5-HT, C48/80 and SLIGRL.

293 pulation in the DR that projects to the VTA (5-HT(DR->VTA) neurons).

294 the predominance of SMN-SN activity, whereas 5-HT signaling favors the predominance of DMN activity,

295 anti-inflammatory functions in M-MO, whereas 5-HT(2B) prevents the degeneration of spinal cord mononu

296 ) engagement in human macrophages, for which 5-HT(2B) signaling remains unknown.

297 gulating expression of genes associated with 5-HT biosynthesis and metabolism.

298 uorescence showed ERICH3 colocalization with 5-HT in vesicle-like structures, and ERICH3 knock-out dr

299 cation of bupropion or hydroxybupropion with 5-HT dose dependently inhibited 5-HT-induced currents in

300 the expression of serotonin receptors, with 5-HT(2B) and 5-HT(7) expression restricted to M-CSF-prim